Xiromerisiou G - Search Results

1

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium. Heckman MG, et al. Among authors: xiromerisiou g. Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17. Neurobiol Aging. 2014. PMID: 23962496 Free PMC article.

2

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.

Xiromerisiou G, Lampropoulos IC, Dermitzakis EV, Vikelis M, Marogianni C, Mysiris D, Argyriou AA. Xiromerisiou G, et al. Toxins (Basel). 2023 Aug 31;15(9):539. doi: 10.3390/toxins15090539. Toxins (Basel). 2023. PMID: 37755965 Free PMC article.

3

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Vikelis M, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Vikelis M, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Jul 6;12(13):4526. doi: 10.3390/jcm12134526. J Clin Med. 2023. PMID: 37445560 Free PMC article.

4

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases.

Sintila SA, Boziki M, Bakirtzis C, Stardeli T, Smyrni N, Nikolaidis I, Parissis D, Afrantou T, Karapanayiotides T, Koutroulou I, Giantzi V, Theotokis P, Kesidou E, Xiromerisiou G, Dardiotis E, Ioannidis P, Grigoriadis N. Sintila SA, et al. Among authors: xiromerisiou g. Medicina (Kaunas). 2023 Jan 30;59(2):266. doi: 10.3390/medicina59020266. Medicina (Kaunas). 2023. PMID: 36837468 Free PMC article.

5

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Vikelis M. Argyriou AA, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Apr 29;12(9):3218. doi: 10.3390/jcm12093218. J Clin Med. 2023. PMID: 37176658 Free PMC article.

6

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.

Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752. Mov Disord. 2006. PMID: 16250025

7

Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Paisán-Ruíz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellström O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB. Paisán-Ruíz C, et al. Among authors: xiromerisiou g. J Med Genet. 2006 Feb;43(2):e9. doi: 10.1136/jmg.2005.036889. J Med Genet. 2006. PMID: 16467219 Free PMC article.

8

Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.

Fung HC, Xiromerisiou G, Gibbs JR, Wu YR, Eerola J, Gourbali V, Hellström O, Chen CM, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Hardy J, Singleton AB. Fung HC, et al. Among authors: xiromerisiou g. Neurodegener Dis. 2006;3(6):327-33. doi: 10.1159/000097301. Neurodegener Dis. 2006. PMID: 17192721

9

Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.

Xiromerisiou G, Hadjigeorgiou GM, Gourbali V, Johnson J, Papakonstantinou I, Papadimitriou A, Singleton AB. Xiromerisiou G, et al. Eur J Neurol. 2007 Jan;14(1):7-11. doi: 10.1111/j.1468-1331.2006.01551.x. Eur J Neurol. 2007. PMID: 17222106

10

BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups.

Xiromerisiou G, Hadjigeorgiou GM, Eerola J, Fernandez HH, Tsimourtou V, Mandel R, Hellström O, Gwinn-Hardy K, Okun MS, Tienari PJ, Singleton AB. Xiromerisiou G, et al. Neurosci Lett. 2007 Mar 19;415(1):59-63. doi: 10.1016/j.neulet.2006.12.038. Epub 2006 Dec 30. Neurosci Lett. 2007. PMID: 17229524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page